Hsu PN - Search Results

1

Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model.

Lin YJ, Huang LR, Yang HC, Tzeng HT, Hsu PN, Wu HL, Chen PJ, Chen DS. Lin YJ, et al. Among authors: hsu pn. Proc Natl Acad Sci U S A. 2010 May 18;107(20):9340-5. doi: 10.1073/pnas.1004762107. Epub 2010 May 3. Proc Natl Acad Sci U S A. 2010. PMID: 20439715 Free PMC article.

2

Lipid raft assembly and Lck recruitment in TRAIL costimulation mediates NF-κB activation and T cell proliferation.

Huang SC, Tsai HF, Tzeng HT, Liao HJ, Hsu PN. Huang SC, et al. Among authors: hsu pn. J Immunol. 2011 Jan 15;186(2):931-9. doi: 10.4049/jimmunol.1001092. Epub 2010 Dec 15. J Immunol. 2011. PMID: 21160038

3

PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.

Tzeng HT, Tsai HF, Liao HJ, Lin YJ, Chen L, Chen PJ, Hsu PN. Tzeng HT, et al. Among authors: hsu pn. PLoS One. 2012;7(6):e39179. doi: 10.1371/journal.pone.0039179. Epub 2012 Jun 22. PLoS One. 2012. PMID: 22761734 Free PMC article.

4

Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy.

Huang YW, Lin SC, Wei SC, Hu JT, Chang HY, Huang SH, Chen DS, Chen PJ, Hsu PN, Yang SS, Kao JH. Huang YW, et al. Among authors: hsu pn. Antivir Ther. 2013;18(7):877-84. doi: 10.3851/IMP2630. Epub 2013 Jun 6. Antivir Ther. 2013. PMID: 23744559

5

Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses.

Tzeng HT, Hsu PN, Chen PJ. Tzeng HT, et al. Among authors: hsu pn. J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:116-9. doi: 10.1111/jgh.12035. J Gastroenterol Hepatol. 2013. PMID: 23855306 Review.

6

Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy.

Huang YW, Hsu CK, Lin SC, Wei SC, Hu JT, Chang HY, Liang CW, Chen DS, Chen PJ, Hsu PN, Yang SS, Kao JH. Huang YW, et al. Among authors: hsu pn, hsu ck. Antivir Ther. 2014;19(7):637-43. doi: 10.3851/IMP2762. Epub 2014 Mar 12. Antivir Ther. 2014. PMID: 24622882

7

Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model.

Tzeng HT, Tsai HF, Chyuan IT, Liao HJ, Chen CJ, Chen PJ, Hsu PN. Tzeng HT, et al. Among authors: hsu pn. PLoS One. 2014 Jul 21;9(7):e103008. doi: 10.1371/journal.pone.0103008. eCollection 2014. PLoS One. 2014. PMID: 25047809 Free PMC article.

8

Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model.

Chyuan IT, Tsai HF, Tzeng HT, Sung CC, Wu CS, Chen PJ, Hsu PN. Chyuan IT, et al. Among authors: hsu pn. Cell Mol Immunol. 2015 May;12(3):317-25. doi: 10.1038/cmi.2015.01. Epub 2015 Feb 9. Cell Mol Immunol. 2015. PMID: 25661729 Free PMC article.

9

Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus.

Sung CC, Horng JH, Siao SH, Chyuan IT, Tsai HF, Chen PJ, Hsu PN. Sung CC, et al. Among authors: hsu pn. Cell Mol Immunol. 2021 Jul;18(7):1772-1782. doi: 10.1038/s41423-020-0376-0. Epub 2020 Feb 28. Cell Mol Immunol. 2021. PMID: 32111985 Free PMC article.

10

Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway.

Chou AH, Tsai HF, Wu YY, Hu CY, Hwang LH, Hsu PI, Hsu PN. Chou AH, et al. Among authors: hsu pn, hsu pi. J Immunol. 2005 Feb 15;174(4):2160-6. doi: 10.4049/jimmunol.174.4.2160. J Immunol. 2005. PMID: 15699147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters